Triphenylphosphonium and D-α-tocopheryl polyethylene glycol 1000 succinate-modified, tanshinone IIA-loaded lipid-polymeric nanocarriers for the targeted therapy of myocardial infarction

被引:37
作者
Zhang, Shouwen [1 ]
Li, Jingfang [1 ]
Hu, Shunpeng [1 ]
Wu, Fangfang [1 ]
Zhang, Xianzhao [1 ]
机构
[1] Linyi Peoples Hosp, Dept Cardiol, 27 Jiefangludongduan, Linyi 276003, Shandong, Peoples R China
关键词
myocardial infarction; mitochondria targeting; lipid-polymeric nanocarriers; D-alpha-tocopheryl polyethylene glycol 1000 succinate; triphenylphosphonium; tanshinone IIA; DRUG-DELIVERY; MIXED MICELLES; IN-VITRO; NANOPARTICLES; MITOCHONDRIA; ISCHEMIA; SYSTEM; CELLS; PHARMACOKINETICS; NANOMEDICINE;
D O I
10.2147/IJN.S165590
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Background: Cardiovascular diseases (CVDs) are the leading causes of mortality worldwide. Currently, the best treatment options for myocardial infarction focus on the restoration of blood flow as soon as possible, which include reperfusion therapy, percutaneous coronary intervention, and therapeutic thrombolytic drugs. Materials and methods: In the present study, we report the development of lipid-polymeric nanocarriers (LPNs) for mitochondria-targeted delivery of tanshinone IIA (TN). D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) was linked to the triphenylphosphonium (TPP) cation. The LPNs were fabricated by nanoprecipitation method. LPNs were evaluated in vitro and in vivo in comparison with free drugs and other similar nanocarriers. Results: The mean diameter of TN/nanoparticles (NPs) was 89.6 nm, while that of TN/LPNs was 121.3 nm. The zeta potential of TN/NPs and TN/LPNs was -33.6 and -22.3 mV, respectively. Compared with free TN and TN/NPs, TN/LPNs exhibited significantly improved compatibility and therapeutic efficiency. In addition, the in vivo pharmacokinetics, biodistribution, and infarct therapy studies in Sprague Dawley rats showed that TPP-TPGS/TN/LPNs had better efficiency than their nonmodified TN/LPNs counterparts in all respects. Conclusion: These results indicated that the TPP-TPGS/TN/LPNs were promising nanocarriers for efficient delivery of cardiovascular drugs and other therapeutic agents for the treatment of CVDs.
引用
收藏
页码:4045 / 4057
页数:13
相关论文
共 46 条
[1]   Recent insights into the biological activities and drug delivery systems of tanshinones [J].
Cai, Yuee ;
Zhang, Wenji ;
Chen, Zirong ;
Shi, Zhi ;
He, Chengwei ;
Chen, Meiwan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :121-130
[2]   A novel local anesthetic system: transcriptional transactivator peptide-decorated nanocarriers for skin delivery of ropivacaine [J].
Chen, Chuanyu ;
You, Peijun .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 :1941-1949
[3]   TPGS-Functionalized Polydopamine-Modified Mesoporous Silica as Drug Nanocarriers for Enhanced Lung Cancer Chemotherapy against Multidrug Resistance [J].
Cheng, Wei ;
Liang, Chaoyu ;
Xu, Lv ;
Liu, Gan ;
Gao, Nansha ;
Tao, Wei ;
Luo, Lingyan ;
Zuo, Yixiong ;
Wang, Xusheng ;
Zhang, Xudong ;
Zeng, Xiaowei ;
Mei, Lin .
SMALL, 2017, 13 (29)
[4]   Biodegradable mixed MPEG-SS-2SA/TPGS micelles for triggered intracellular release of paclitaxel and reversing multidrug resistance [J].
Dong, Kai ;
Yan, Yan ;
Wang, Pengchong ;
Shi, Xianpeng ;
Zhang, Lu ;
Wang, Ke ;
Xing, Jianfeng ;
Dong, Yalin .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :5109-5123
[5]   RGD modified and PEGylated lipid nanoparticles loaded with puerarin: Formulation, characterization and protective effects on acute myocardial ischemia model [J].
Dong, Zhaoqiang ;
Guo, Jing ;
Xing, Xiaowei ;
Zhang, Xuguang ;
Du, Yimeng ;
Lu, Qinghua .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 :297-304
[6]   Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling [J].
Ferreira, Monica P. A. ;
Ranjan, Sanjeev ;
Kinnunen, Sini ;
Correia, Alexandra ;
Talman, Virpi ;
Makila, Ermei ;
Barrios-Lopez, Brianda ;
Kemell, Marianna ;
Balasubramanian, Vimalkumar ;
Salonen, Jarno ;
Hirvonen, Jouni ;
Ruskoaho, Heikki ;
Airaksinen, Anu J. ;
Santos, Helder A. .
SMALL, 2017, 13 (33)
[7]   Transferrin-modified nanostructured lipid carriers as multifunctional nanomedicine for codelivery of DNA and doxorubicin [J].
Han, Yiqun ;
Zhang, Ying ;
Li, Danni ;
Chen, Yuanyuan ;
Sun, Jiping ;
Kong, Fansheng .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2014, 9 :4107-4115
[8]   Folic acid-functionalized drug delivery platform of resveratrol based on Pluronic 127/D-α-tocopheryl polyethylene glycol 1000 succinate mixed micelles [J].
Hao, Jifu ;
Tong, Tiantian ;
Jin, Kai ;
Zhuang, Qiannan ;
Han, Te ;
Bi, Yanping ;
Wang, Jianzhu ;
Wang, Xiaodan .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 :2279-2292
[9]  
Ho Yan Teck, 2016, Nanomedicine (Lond), V11, P693, DOI 10.2217/nnm.16.6
[10]   Synergistic apoptotic effects of apigenin TPGS liposomes and tyroservatide: implications for effective treatment of lung cancer [J].
Jin, Xin ;
Yang, Qing ;
Zhang, Youwen .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2017, 12 :5109-5118